After, since 2004 in Colombia around 10 clinical trials to test possible vaccines against Dengue, Invima confirmed to Snail Radio than two immunizers to combat this disease, produced by the pharmaceutical Sanofi, they already have a sanitary registration, which allows them to be marketed and distributed in the country.
“The validity of health register for these vaccines it is until the year 2025. One of them is unit dose and the other is multi-dosis. Both immunizers are from the Sanofi pharmaceutical company and are the only ones that until moment they have this authorization. We also have another one that is in progress, but it is still in the process of Review Commission of Invima can evaluate all the information provided by the user in order to proceed with the authorization of the Registration”, Revealed Pahola Thumb, coordinator of the Invima Clinical Research Group.
Pulgarín also confirmed that, currently Progress is being made in conducting three other clinical trials of vaccines against Dengue, which include around 3,307 volunteers that continue to be recruited for Colombia.
–
